NEW YORK (GenomeWeb News) — Oxford Gene Technology, St. George’s University of London, and St. George’s Healthcare NHS plan to develop a single-platform microarray that could “diagnose multiple sexually transmitted [diseases],” OGT said today.
 
OGT said the test would have the capacity to diagnose many STD pathogens in a single specimen and would offer cost-effective results on the same day. It did not elaborate.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.